Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.

International journal of cancer - 1 Jun 2024

Gu Zhenbang, Huang Peng, Zhao Jiali, Luo Chen, Liao Lingmin, Liu Anwen, Huang Long

Abstract excerpt

Bilateral diffuse metastatic lung adenocarcinoma (BLDM-LUAD) is a special imaging pattern of lung adenocarcinoma (LUAD). We retrospectively assessed survival outcomes and co-mutation characteristics of BLDM-LUAD patients harboring epidermal growth factor receptor (EGFR) mutations who were treated with EGFR-yrosine kinase inhibitors (TKIs). From May 2016 to May 2021, among 458 patients who submitted samples for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to MET gene

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Share to Protein Kinase Inhibitors

Source

Identifiers

PMID: 38353428
DOI: 10.1002/ijc.34878

Genes

EGFR
ATM
KRAS
MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bilateral diffuse metastases in advanced lung adenocarcinoma harboring EGFR mutations was associated with a favorable prognosis to EGFR-TKIs.PMID 38353428Read ↗

Radiological classification, gene-mutation status, and surgical prognosis of synchronous multiple primary lung cancer.Semantic proximity Read ↗

The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma.Semantic proximity Read ↗

Clinical Features and Surgical Treatment of Synchronous Multiple Primary Lung Adenocarcinomas With Different EGFR MutationsSemantic proximity Read ↗

Case Report: A Bilateral Synchronous Primary Non-Small Cell Lung Cancer Patient With Two Different EGFR Mutations.Semantic proximity Read ↗

Title: Lung-molGPA in EGFR-mutated Adenocarcinoma: Prognostic Implications of Molecular Subtypes and Targeted TherapiesSemantic proximity Read ↗

Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spacesSemantic proximity Read ↗

Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report.Semantic proximity Read ↗

Confronting synchronous multiple primary lung cancers: Navigating the intersection of challenges and opportunities.Semantic proximity Read ↗

Genetic Alterations in Preinvasive Lung Synchronous Lesions.Semantic proximity Read ↗

Synchronous primary lung cancer and epidermal growth factor receptor mutation.Semantic proximity Read ↗

Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis.Semantic proximity Read ↗

Distinct gene mutation profiles among multiple and single primary lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.